On (31, 413). Anlotinib may inhibit far more targets than that do other RTK inhibitors,
On (31, 413). Anlotinib may inhibit far more targets than that do other RTK inhibitors, such as pazopanib, sunitinib, and sorafenib. All targets of anlotinib and other RTK inhibitors are…